A214 (Levetiracetam extended release 750 mg)
Pill imprint A214 has been identified as Levetiracetam extended release 750 mg.
Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for A214 (Levetiracetam extended release 750 mg)
More about levetiracetam
- Levetiracetam extended-release tablets
- Levetiracetam solution
- Levetiracetam tablets
- Levetiracetam (Advanced Reading)
- Levetiracetam Intravenous (Advanced Reading)